awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26782424-3AAE88AB-132D-43B5-A775-4C012BF2481F
Q26782424-3AAE88AB-132D-43B5-A775-4C012BF2481F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26782424-3AAE88AB-132D-43B5-A775-4C012BF2481F
Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management
P2860
Q26782424-3AAE88AB-132D-43B5-A775-4C012BF2481F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26782424-3AAE88AB-132D-43B5-A775-4C012BF2481F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10b2166665d704ab673c8ce3b3702919329e9b49
P2860
Commentary: rituximab, adalimumab, etanercept, tocilizumab--are biologics the future for Graves' orbitopathy?